Merger News: Pharma company gave a big update on the merger, keep an eye on the stock

Mankind Pharma has informed after the market closed on Friday that Mankind Pharma has received NCLT approval for the merger of BSV Pharma with Bharat Serum and Vaccines. The company said in the information given to the exchange, "The National Company Law Tribunal, Mumbai Bench, (NCLT) in its hearing held today i.e. March 28, 2025 approved the scheme of merger of BSV Pharma Private Limited, a material subsidiary of Mankind Pharma Limited, with Bharat Serum and Vaccines Limited, a step down subsidiary and their respective shareholders under sections 230 and 232 of the Companies Act, 2013.

The scheme will become effective from the appointed date i.e. May 9, 2022, when the certified copy of the order passed by the NCLT will be filed by both the companies with the Registrar of Companies. The company said that the certified copy of the order is awaited. Once the certified copy of the order is filed with the Registrar of Companies, the transferor company will be dissolved without winding up. BSV Pharma is currently engaged in the business of marketing, distribution, purchase and sale of women's healthcare products in India. Stock performance On Friday, the company's stock closed at Rs 2,423.60, down 1.16 per cent. In the last one year, the company's stock has seen a rise of 5.34 per cent. 

Read More: Stock Crash: Lower circuit imposed on stock after SEBI's strict action, Stock Split also stopped